SenesTech, Inc. Announces Pricing Of $5M Public Offering Of Up To 1,428,572 Shares At A Price Of $3.50 Per Share
SenesTech, Inc. (NASDAQ:SNES, ", , SenesTech", , or the ", , Company", , )))) (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
Gainers
Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday.
S&P 500 Rises 0.8%; Sea Shares Spike Higher
U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Tuesday.
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split.
S&P 500 Rises Over 1%; Sea Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.
Nasdaq Jumps Over 200 Points; AMMO Shares Plunge
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.
SenesTech Announces 1-For-20 Reverse Stock Split; Will Begin Trading On A Split-Adjusted Basis When The Market Opens On November 16, 2022
Common Stock Will Begin Trading on a Split-Adjusted Basis on November 16, 2022
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers
NexImmune (NASDAQ:NEXI) shares rose 38.8% to $0.7 during Thursday's pre-market session. The market value of their outstanding shares is at $16.9 million.